LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

Search

Odonate Therapeutics Inc

Închisă

0

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

Indicatori cheie

By Trading Economics

Odonate Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

10 dec. 2025, 22:02 UTC

Câștiguri

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

10 dec. 2025, 21:46 UTC

Câștiguri

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

10 dec. 2025, 23:52 UTC

Achiziții, Fuziuni, Preluări

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

10 dec. 2025, 23:43 UTC

Market Talk

Nikkei May Rise After Fed Rate Cut -- Market Talk

10 dec. 2025, 23:36 UTC

Market Talk

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

10 dec. 2025, 23:20 UTC

Câștiguri

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

10 dec. 2025, 23:15 UTC

Câștiguri

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

10 dec. 2025, 22:59 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

10 dec. 2025, 22:45 UTC

Market Talk

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

10 dec. 2025, 22:40 UTC

Câștiguri

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 dec. 2025, 22:06 UTC

Achiziții, Fuziuni, Preluări

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 dec. 2025, 22:06 UTC

Câștiguri

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 dec. 2025, 22:02 UTC

Câștiguri

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 dec. 2025, 22:00 UTC

Câștiguri

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

10 dec. 2025, 21:53 UTC

Câștiguri

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 dec. 2025, 21:50 UTC

Achiziții, Fuziuni, Preluări

Investors Bet That a Higher Bid for Warner Is Coming -- Update

10 dec. 2025, 21:50 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Financial Services Roundup: Market Talk

10 dec. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 dec. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10 dec. 2025, 21:45 UTC

Achiziții, Fuziuni, Preluări

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 dec. 2025, 21:33 UTC

Câștiguri

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

10 dec. 2025, 21:32 UTC

Câștiguri

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 dec. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

10 dec. 2025, 21:25 UTC

Câștiguri

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 dec. 2025, 21:18 UTC

Achiziții, Fuziuni, Preluări

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

10 dec. 2025, 21:16 UTC

Câștiguri

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

10 dec. 2025, 21:15 UTC

Achiziții, Fuziuni, Preluări

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

10 dec. 2025, 21:15 UTC

Câștiguri

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

10 dec. 2025, 21:14 UTC

Câștiguri

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

10 dec. 2025, 21:14 UTC

Câștiguri

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

Comparație

Modificare preț

Odonate Therapeutics Inc Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

$

Despre Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat